Knowledge Center
China's innovative therapies lead new cancer battle
China approved satri-cel as the world’s first CAR-T product for a solid tumor, extending a treatment once limited commercially to blood cancers.
China Completes First Demo Unit of Next-gen Heavy-ion Cancer Therapy Accelerator
China completed a compact next-generation heavy-ion accelerator in Huizhou, with clinical trials expected by the end of 2026 and potential for wider cancer treatment.
Institute of Modern Physics, CAS
Chinese Surgical Robots Surpass Da Vinci in Domestic Market Share, Expanding into Global Remote Surgery
MicroPort MedBot’s Toumai overtook Da Vinci in China’s laparoscopic surgical-robot market during January–May 2026, marking a milestone for domestic systems.
In China, A.I. Is Finding Deadly Tumors That Doctors Might Miss
PANDA reviewed more than 180,000 routine CT scans at a Ningbo hospital, helping detect about two dozen pancreatic cancers, including 14 early-stage cases.
China’s domestic BCI systems prove effectiveness, potential to bridge biological and artificial intelligence
Tsinghua’s wireless NEO implant enabled two paralyzed trial participants to control devices with their thoughts, with one recovering some grasping function.
57-year-old patient with end-stage heart failure receives Rocket Heart
China’s HeartCon LVAD supported a 57-year-old patient with end-stage heart failure, while a 75-gram next-generation version advanced through clinical trials.
Chinese trial backs base-editing drug for thalassaemia
All five patients in a Chinese trial stopped transfusions after one infusion of CS-101, a base-editing therapy for transfusion-dependent beta-thalassaemia.
Pig-to-human kidney transplant in China offers hope to millions in organ crisis
A gene-edited pig kidney produced urine and maintained early function after transplantation into a 69-year-old woman with end-stage kidney disease in China.
World-First Stem Cell Treatment Reverses Diabetes for a Patient in China, Study Suggests
Chinese researchers reprogrammed a woman's own cells into insulin-producing islets; more than a year after transplantation, she remained free of insulin injections.
New kit for lung cancer early detection approved for market in China
A Chinese blood test analyzing 13 tumor-autoantibody biomarkers has received Class III registration, offering a new way to flag malignant lung nodules earlier.
3D-printed medical devices gain ground
China's 3D-printed medical device sector is expanding, highlighted by NMPA approval of Wedo-Bio's porous titanium cage for degenerative spinal diseases.
Next-gen multimodal large model cuts cost of lung cancer genetic testing
DeepGEM 2.0 uses pathology images to pre-screen lung cancer gene targets in about one minute, with validation planned across 50 medical institutions.
Ancient medicine pairs up with AI
China is pairing AI, stricter standards and smart manufacturing with TCM to improve scientific validation, production consistency and global competitiveness.
VenusA-Plus four-year clinical data released: Comparable or superior to international counterparts
Venus Medtech reports four-year follow-up data for VenusA-Plus, China's first retrievable TAVR device, showing stable valve performance and no new cardiac deaths.
Chinese team offers remote treatment
A Chinese team in Rome used a domestic robot and 5G+ link to remove a patient's prostate cancer in Beijing, more than 8,000 kilometers away.
Deep brain stimulation successful for one in two patients with treatment-resistant severe depression and anxiety
In a 26-patient open-label trial at Shanghai's Ruijin Hospital, DBS improved depression and anxiety in half of participants, while theta activity helped predict response.
Country's first robotic heart transplant a success
Chinese doctors completed the country’s first robotic heart transplant without splitting the patient’s breastbone. The Xi’an procedure was the third of its kind worldwide.
Chinese hospitals accelerate AI-powered health care transformation
Chinese hospitals are embedding large language models into triage, imaging and medical documentation, moving AI from laboratory trials into everyday clinical workflows.
From rarity to recognition: A brighter future for rare disease patients
China’s rare-disease collaboration network now links 419 hospitals nationwide, helping shorten average diagnosis time from more than four years to four weeks.
A novel framework integrating AI model and enzymological experiments promotes identification of SARS-CoV-2 3CL protease inhibitors and activity-based probe
Chinese researchers developed AIMEE, an iterative AI-and-experiment framework that identified six novel SARS-CoV-2 3CL protease inhibitors, four with IC50 values below 3 μM.
Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening
A Chinese team’s COATE-seq method separates fetal and maternal cfDNA, enabling broader non-invasive screening for chromosomal and monogenic disorders.
Chinese scientists develop world’s first bionic auditory neural interface, enabling artificial auditory nerve to ‘understand’ sounds
Nankai University researchers say their bionic auditory neural interface could help cochlear implant technology move beyond hearing sounds toward understanding them.
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
Pfizer signed a licensing agreement worth about $6 billion with China’s 3SBio for SSGJ-707, a cancer drug candidate in clinical trials.
Reuters (via The Economic Times)
Augmented Reality Navigation for Stereoscopic Laparoscopic Anatomical Hepatectomy of Primary Liver Cancer: Preliminary Experience
A Chinese clinical study found that laparoscopic augmented-reality navigation helped identify liver anatomy and reduced bleeding and hospital stays in liver-cancer surgery.